Paraskevas, Kosmas and Mikhailidis, Dimitri P. and Antignani, Pier Luigi and Ascher, Enrico and Baradaran, Hediyeh and Bokkers, Reinoud P. H. and Cambria, Richard P. and Comerota, Anthony J. and Dardik, Alan and Davies, Alun H. and Eckstein, Hans-Henning and Faggioli, Gianluca and Fernandes, Jose Fernandes E. and Fraedrich, Gustav and Geroulakos, George and Gloviczki, Peter and Golledge, Jonathan and Gupta, Ajay and Jezovnik, Mateja K. and Kakkos, Stavros K. and Katsiki, Niki and Knoflach, Michael and Kooi, M. Eline and Lanza, Gaetano and Lavenson, George S. and Liapis, Christos D. and Loftus, Ian M. and Mansilha, Armando and Millon, Antoine and Nicolaides, Andrew N. and Pini, Rodolfo and Poredos, Pavel and Proczka, Robert M. and Ricco, Jean-Baptiste and Riles, Thomas S. and Ringleb, Peter Arthur and Rundek, Tatjana and Saba, Luca and Schlachetzki, Felix and Silvestrini, Mauro and Spinelli, Francesco and Stilo, Francesco and Sultan, Sherif and Suri, Jasjit S. and Svetlikov, Alexei and Zeebregts, Clark J. and Chaturvedi, Seemant (2022) Comparison of Recent Practice Guidelines for the Management of Patients With Asymptomatic Carotid Stenosis. ANGIOLOGY, 73 (10). pp. 903-910. ISSN 0003-3197, 1940-1574
Full text not available from this repository. (Request a copy)Abstract
Despite the publication of several national/international guidelines, the optimal management of patients with asymptomatic carotid stenosis (AsxCS) remains controversial. This article compares 3 recently released guidelines (the 2020 German-Austrian, the 2021 European Stroke Organization [ESO], and the 2021 Society for Vascular Surgery [SVS] guidelines) vs the 2017 European Society for Vascular Surgery (ESVS) guidelines regarding the optimal management of AsxCS patients. The 2017 ESVS guidelines defined specific imaging/clinical parameters that may identify patient subgroups at high future stroke risk and recommended that carotid endarterectomy (CEA) should or carotid artery stenting (CAS) may be considered for these individuals. The 2020 German-Austrian guidelines provided similar recommendations with the 2017 ESVS Guidelines. The 2021 ESO Guidelines also recommended CEA for AsxCS patients at high risk for stroke on best medical treatment (BMT), but recommended against routine use of CAS in these patients. Finally, the SVS guidelines provided a strong recommendation for CEA+BMT vs BMT alone for low-surgical risk patients with >70% AsxCS. Thus, the ESVS, German-Austrian, and ESO guidelines concurred that all AsxCS patients should receive risk factor modification and BMT, but CEA should or CAS may also be considered for certain AsxCS patient subgroups at high risk for future ipsilateral ischemic stroke.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | TRANSCAROTID ARTERY REVASCULARIZATION; VASCULAR-SURGERY GUIDELINES; SMOKING-CESSATION RATES; FOLLOW-UP; ENDARTERECTOMY; DIAGNOSIS; SOCIETY; asymptomatic carotid stenosis; best medical treatment; stroke; carotid endarterectomy; carotid artery stenting; guidelines |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Neurologie |
| Depositing User: | Petra Gürster |
| Date Deposited: | 05 Sep 2023 10:18 |
| Last Modified: | 05 Sep 2023 10:18 |
| URI: | https://pred.uni-regensburg.de/id/eprint/58829 |
Actions (login required)
 |
View Item |
